查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829308

2025年全球心血管植入市場報告

Cardiovascular Implants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心血管植入市場規模強勁成長，從2024年的268億美元增加至2025年的286.8億美元，複合年成長率為7.0%。預測期內的成長歸因於人口老化、心血管風險的增加、生活方式相關的心血管風險因素、診斷技術的改進、認知度的提高和篩檢計畫的推進，以及政府在心血管健康方面的舉措。

預計未來幾年心血管植入市場將強勁成長，到2029年將達到367.6億美元，複合年成長率為6.4%。預測期內的成長歸因於個人化醫療方法、對年複合成長率手術的關注、心血管研究的全球合作、強調預防性干預的醫療保健政策以及以患者為中心的心血管護理。預測期內的主要趨勢包括藥物釋放型支架的進步、下一代心臟瓣膜的興起、人工智慧 (AI) 整合度的提高、對微創植入手術的關注，以及個人化、患者專用植入和無導線心律調節器的開發。

心血管植入是透過手術植入心血管系統，用於治療心臟和血管疾病的醫療設備。這些器械被策略性地植入心血管系統，以治療動脈阻塞、心律不整和瓣膜缺陷等疾病。其主要目標是恢復正常的心臟功能並改善血液循環。

心血管植入的主要產品類型包括冠狀動脈支架、植入式心臟整流去顫器(ICD)、心臟瓣膜、植入式心臟節律器、心臟再同步治療 (CRT) 裝置以及周邊支架。冠狀動脈支架是插入狹窄或阻塞的冠狀動脈以保持其暢通的小網狀管。製造這些植入的材料多種多樣，包括金屬和合金、聚合物和生物材料。其應用包括治療心律不整、急性心肌梗塞和心肌缺血。這些心血管植入的最終用戶包括醫院、門診手術中心和心臟中心等各種機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供心血管植入市場統計數據，包括全球市場規模、區域佔有率、競爭對手的心血管植入市場佔有率、詳細的心血管植入細分市場、市場趨勢和商機，以及您在心血管植入行業取得成功所需的數據。本心血管植入市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，植入您提供所需的一切觀點。

我們預測未來五年該市場將成長6.4%，較先前預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自義大利和瑞典等主要地區的鈷鉻合金環和聚合物瓣環成形帶環狀成形術關稅直接影響美國，這可能導致結構性心臟介入治療成本增加和瓣膜修復手術延誤。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

預計心臟病患病率的上升將在未來幾年推動心血管植入市場的成長。心臟病包括影響心臟和血管的各種疾病，例如冠狀動脈疾病、心臟衰竭、心律不整和瓣膜疾病。冠狀動脈疾病和心臟衰竭等心臟病的增加推動了對包括支架和心臟衰竭在內的心血管植入的需求。這些植入支持心臟衰竭患者的心臟功能和血液循環，調節心律並監測心臟活動。例如，2024 年 9 月，英國心臟基金會 (BHF) 報告稱，英國約有 760 萬人患有心臟和循環系統疾病，BHF 是一家總部位於英國的慈善機構，致力於資助和提高人們對心臟和循環系統疾病研究的認知。到 2030 年，這個數字可能會增加 100 萬，到 2040 年再增加 200 萬。因此，心臟病患病率的上升正在推動心血管植入市場的發展。

預計未來幾年，老齡化人口的不斷成長將推動心血管植入市場的成長。人口老化反映了一種人口結構變化，其特徵是60歲及以上人口比例的上升。心血管植入在管理和治療老年人常見的心血管疾病方面發揮關鍵作用，有助於改善生活品質、延長壽命並改善整體健康。根據世界衛生組織（WHO）2022年10月的數據，預計到2030年，全球整體六分之一的人口將達到60歲及以上，到2050年，這一數字將達到21億。因此，老齡化人口的不斷成長是推動心血管植入市場成長的關鍵因素。

心血管植入市場的主要企業越來越注重整合包括人工智慧 (AI) 在內的先進技術，以最佳化市場利潤並改善患者的治療和護理。心臟監測技術的進步包括持續追蹤和記錄患者的心臟活動，以診斷和管理心臟疾病。 2023 年 6 月，BIOTRONIK SE & Co. KG 推出了 BIOMONITOR IV，這是世界上第一款將 SmartECG 技術與人工智慧結合的植入式心臟監測器 (ICM)。這項技術創新將誤報率降低了 86%，同時在檢測實際發作方面保持了 98% 的準確率。 BIOMONITOR IV 還具有其他優勢，包括更長的電池壽命和無線連接，可實現無縫資料傳輸和遠端監控，從而減少了頻繁就診的需求。

2023年4月，雅培實驗室以8.9億美元收購了心血管系統公司（Cardiovascular Systems Inc.），以增強其血管疾病治療解決方案。此次策略性收購使心血管系統公司完全子公司，並鞏固了雅培在提供周邊血管和冠狀動脈疾病創新解決方案方面的地位。

心血管植入市場包括動脈瘤支架血管支架、心臟再同步治療 (CRT) 裝置、心室輔助人工心臟和周邊支架的銷售。該市場的價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心血管植入：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球心血管植入市場：成長率分析
  • 全球心血管植入市場表現：規模與成長，2019-2024
  • 全球心血管植入市場預測：2024-2029年及2034年規模與成長
  • 全球心血管植入：總目標市場（TAM）

第6章 市場細分

  • 全球心血管植入市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 冠狀動脈支架
  • 植入式心臟整流去顫器（ICD）
  • 心臟瓣膜
  • 植入式心臟節律器
  • 心臟再同步治療 (CRT) 設備
  • 外周支架
  • 全球心血管植入市場：按材料、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 金屬和合金
  • 聚合物
  • 生物材料
  • 全球心血管植入市場：應用、績效及預測（2019-2024年、2024-2029年、2034年）
  • 心律不整
  • 急性心肌梗塞
  • 心肌缺血
  • 其他用途
  • 全球心血管植入市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 心臟中心
  • 全球心血管植入市場：細分：冠狀動脈支架（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型支架
  • 裸金屬支架
  • 生物可吸收支架
  • 全球心血管植入市場：植入式心臟整流去顫器(ICD) 細分，類型，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔ICD
  • 雙腔ICD
  • 雙心室ICD
  • 全球心血管植入市場：依心臟瓣膜類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟瓣膜
  • 生物心臟瓣膜
  • 經導管心臟瓣膜
  • 全球心血管植入市場：植入式心臟節律器細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔心律調節器
  • 雙腔心律調節器
  • 雙心室節律器
  • 全球心血管植入市場：心臟再同步治療 (CRT) 設備細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • CRT-P 設備（心律調節器）
  • CRT-D 裝置（去心房顫動）
  • 全球心血管植入市場：周邊支架細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 頸動脈支架
  • 腎動脈支架
  • 股動脈支架

第7章 區域和國家分析

  • 全球心血管植入市場：區域分析、預測與趨勢（2019-2024 年、2024-2029 年及 2034 年）
  • 全球心血管植入市場：各國市場表現及預測（2019-2024年、2024-2029年、2034年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心血管植入市場：競爭格局
  • 心血管植入市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • WL Gore & Associates Inc.
  • Cook Medical Incorporated
  • Teleflex Incorporated
  • Kyoto Medical Planning Co. Ltd.
  • Abiomed Inc.
  • Livanova PLC
  • BIOTRONIK SE & Co. KG
  • CryoLife Inc.
  • Endologix Inc.
  • Sorin Group
  • Berlin Heart GmbH
  • REVA Medical LLC.
  • Syncardia Systems LLC
  • Elixir Medical Corporation
  • Fortimedix Surgical BV

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年心血管植入市場：提供新機會的國家
  • 2029年心血管植入市場：細分領域帶來新機會
  • 2029年心血管植入市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27629u

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $26.8 billion in 2024 to $28.68 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to aging population and cardiovascular risk, lifestyle-related cardiovascular risk factors, improvements in diagnostic technologies, growing awareness and screening programs, government initiatives for cardiovascular health.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $36.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to personalized medicine approaches, focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, patient-centric cardiovascular care. Major trends in the forecast period include advancements in drug-eluting stents, rise of next-generation heart valves, increasing integration of artificial intelligence (ai), focus on minimally invasive implantation techniques, personalized and patient-specific implants, development of leadless pacemakers.

The forecast of 6.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on cobalt-chromium alloy rings and polymer-based annuloplasty bands, sourced from key regions such as Italy and Sweden, which could lead to increased costs for structural heart interventions and potential delays in valve repair procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.

The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

North America was the largest region in the cardiovascular implants market in 2024. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Subsegments:
  • 1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents
  • 2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
  • 3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
  • 4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
  • 5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
  • 6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Cook Medical Incorporated; Teleflex Incorporated; Kyoto Medical Planning Co. Ltd.; Abiomed Inc.; Livanova PLC; BIOTRONIK SE & Co. KG; CryoLife Inc.; Endologix Inc.; Sorin Group; Berlin Heart GmbH; REVA Medical LLC.; Syncardia Systems LLC; Elixir Medical Corporation; Fortimedix Surgical B.V.; AMG International GmbH; CHF Solutions Inc.; Proxy Biomedical Ltd.; Calon Cardio-Technology Ltd.; InspireMD Inc.; Neovasc Inc.; Shree Pacetronix Ltd.; Vascutek Ltd (Terumo Corporation)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular Implants Market Characteristics

3. Cardiovascular Implants Market Trends And Strategies

4. Cardiovascular Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiovascular Implants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiovascular Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiovascular Implants Market Growth Rate Analysis
  • 5.4. Global Cardiovascular Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiovascular Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiovascular Implants Total Addressable Market (TAM)

6. Cardiovascular Implants Market Segmentation

  • 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Stent
  • Implantable Cardioverter Defibrillator (ICD)
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Peripheral Stent
  • 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metals and Alloys
  • Polymers
  • Biological Materials
  • 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arrhythmias
  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Other Applications
  • 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • 6.5. Global Cardiovascular Implants Market, Sub-Segmentation Of Coronary Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioabsorbable Stents
  • 6.6. Global Cardiovascular Implants Market, Sub-Segmentation Of Implantable Cardioverter Defibrillator (ICD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber ICD
  • Dual-Chamber ICD
  • Biventricular ICD
  • 6.7. Global Cardiovascular Implants Market, Sub-Segmentation Of Heart Valve, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Heart Valves
  • Biological Heart Valves
  • Transcatheter Heart Valves
  • 6.8. Global Cardiovascular Implants Market, Sub-Segmentation Of Implanted Cardiac Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemaker
  • Dual-Chamber Pacemaker
  • Biventricular Pacemaker
  • 6.9. Global Cardiovascular Implants Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT) Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P Devices (Pacemakers)
  • CRT-D Devices (Defibrillators)
  • 6.10. Global Cardiovascular Implants Market, Sub-Segmentation Of Peripheral Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carotid Artery Stents
  • Renal Artery Stents
  • Femoral Artery Stents

7. Cardiovascular Implants Market Regional And Country Analysis

  • 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiovascular Implants Market

  • 8.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiovascular Implants Market

  • 9.1. China Cardiovascular Implants Market Overview
  • 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiovascular Implants Market

  • 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiovascular Implants Market

  • 11.1. Japan Cardiovascular Implants Market Overview
  • 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiovascular Implants Market

  • 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiovascular Implants Market

  • 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiovascular Implants Market

  • 14.1. South Korea Cardiovascular Implants Market Overview
  • 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiovascular Implants Market

  • 15.1. Western Europe Cardiovascular Implants Market Overview
  • 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiovascular Implants Market

  • 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiovascular Implants Market

  • 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiovascular Implants Market

  • 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiovascular Implants Market

  • 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiovascular Implants Market

  • 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiovascular Implants Market

  • 21.1. Eastern Europe Cardiovascular Implants Market Overview
  • 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiovascular Implants Market

  • 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiovascular Implants Market

  • 23.1. North America Cardiovascular Implants Market Overview
  • 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiovascular Implants Market

  • 24.1. USA Cardiovascular Implants Market Overview
  • 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiovascular Implants Market

  • 25.1. Canada Cardiovascular Implants Market Overview
  • 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiovascular Implants Market

  • 26.1. South America Cardiovascular Implants Market Overview
  • 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiovascular Implants Market

  • 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiovascular Implants Market

  • 28.1. Middle East Cardiovascular Implants Market Overview
  • 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiovascular Implants Market

  • 29.1. Africa Cardiovascular Implants Market Overview
  • 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 30.1. Cardiovascular Implants Market Competitive Landscape
  • 30.2. Cardiovascular Implants Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiovascular Implants Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Cook Medical Incorporated
  • 31.3. Teleflex Incorporated
  • 31.4. Kyoto Medical Planning Co. Ltd.
  • 31.5. Abiomed Inc.
  • 31.6. Livanova PLC
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. Endologix Inc.
  • 31.10. Sorin Group
  • 31.11. Berlin Heart GmbH
  • 31.12. REVA Medical LLC.
  • 31.13. Syncardia Systems LLC
  • 31.14. Elixir Medical Corporation
  • 31.15. Fortimedix Surgical B.V.

32. Global Cardiovascular Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiovascular Implants Market

34. Recent Developments In The Cardiovascular Implants Market

35. Cardiovascular Implants Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiovascular Implants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiovascular Implants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiovascular Implants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer